Skip to content

Inhibrx Biosciences

US · INBX #3022 by market cap Listed 2024
93.36 -0.05 -0.05%
Live - 5344 symbols - heartbeat 245s ago · 2026-10-07 19:54
After-hours 93.41 +0.05%
Market cap
1.37B
P/B
-25.93
EPS
-9.04
Reader sentiment Are you bullish or bearish on INBX?

Anonymous reader poll. Unscientific, not investment advice.

Analyst consensus 3 analysts

Buy
Avg price target 266.67 +185.6%
Price target rangecurrent 93.36
Low230.00
Avg266.67
High325.00
Buy 100% Hold 0% Sell 0%
Recent ratings (14)
DateFirmAnalystRatingTarget
2026-09-09 H.C. Wainwright -- BUY 245.00
2026-09-08 LifeSci Capital -- BUY 230.00
2026-08-24 H.C. Wainwright -- BUY 245.00
2026-08-21 Stifel -- BUY 325.00
2026-08-14 LifeSci Capital -- BUY 230.00
2026-08-14 Stifel -- BUY 325.00
2026-06-02 Stifel -- BUY 325.00
2026-05-16 LifeSci Capital -- BUY 230.00
2026-05-15 Stifel -- BUY 325.00
2026-05-11 LifeSci Capital -- BUY 230.00
2026-04-25 LifeSci Capital -- BUY 200.00
2026-04-24 LifeSci Capital -- BUY 200.00
2026-04-22 Stifel -- BUY 300.00
2026-04-17 Stifel -- BUY 150.00

Quant vs Street three independent views, side by side

Momentum strategy signal
Buy
Analyst consensus
Buy

All 2 views agree: bullish.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Price target trend monthly average, last 3 years

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.